Form 4: IDEAYA Biosciences Director Acquires Stock Options

IDEAYA Biosciences Director Malcolm Garret Hampton acquired 20,000 stock options with an exercise price of $30.57.

Summary

• Malcolm Garret Hampton, a Director at IDEAYA Biosciences, Inc. (IDYA), acquired 20,000 stock options on June 16, 2026.
• The options have an exercise price of $30.57 and an expiration date of June 16, 2036.
• These options represent the right to buy 20,000 shares of common stock.
• The vesting schedule indicates that 100% of the shares subject to the option will vest on the earlier of the first anniversary of the grant date or immediately prior to the Annual Meeting following the grant date, provided the Reporting Person remains in service on the Board.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard compensation and incentive mechanism for a director rather than a significant new development.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The vesting schedule is tied to continued service, aligning the director's incentives with the company's long-term success.

Future Outlook

The vesting of the stock options is contingent upon the director's continued service and is scheduled to occur on the first anniversary of the grant date or prior to the next Annual Meeting, whichever comes first.

Industry Context

StockSavvy.ai notes that the acquisition of stock options by a director is a common practice in the biotechnology and pharmaceutical sectors, often used as a long-term incentive to align executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The acquisition of options by a director can be viewed positively as it aligns director incentives with long-term company performance. However, the dilutive effect of future share issuance upon exercise should be considered.

Next Steps

• Vesting of 100% of the stock options on the earlier of the first anniversary of the grant date or immediately prior to the Annual Meeting following the grant date, subject to continued service.

Key Dates

Keywords

IDEAYA Biosciences, IDYA, Form 4, Stock Options, Director, Beneficial Ownership, Securities Exchange Act